Inotropes and vasopressors: more than haemodynamics!

Area of Science:

• Pharmacology
• Critical Care Medicine
• Cardiovascular Physiology

Background:

• Circulatory shock presents with hypotension, impaired tissue oxygenation, and requires interventions like fluid resuscitation, inotropes, and vasopressors.
• Catecholamines are the standard treatment for shock, but their efficacy and safety are based on empirical data rather than robust clinical evidence.
• The optimal choice of catecholamines or alternative agents for specific shock conditions remains a subject of ongoing debate.

Purpose of the Study:

• To review the pharmacology and clinical data of various agents used in treating circulatory shock.
• To evaluate the therapeutic use of endogenous catecholamines, synthetic derivatives, vasopressin analogues, PDE inhibitors, and levosimendan.
• To highlight the gap in understanding the clinical effects of these treatments despite established receptor pharmacology.

Main Methods:

• Literature review of pharmacological properties and clinical data.
• Analysis of endogenous catecholamines, synthetic derivatives, vasopressin, PDE inhibitors, and levosimendan.
• Examination of evidence supporting the use of different vasopressors and inotropes in shock management.

Main Results:

• Catecholamines are the primary therapeutic choice for shock, yet their selection is largely empirical.
• Evidence suggests variability in effectiveness and safety among different catecholamines, but definitive comparisons are lacking.
• The clinical impact of vasopressors and inotropes is not fully elucidated, despite known receptor mechanisms.

Conclusions:

• Further research is critical to guide the selection of the most effective and safest vasopressor or inotrope for specific clinical scenarios in circulatory shock.
• A deeper understanding of the clinical effects of shock treatments is needed to move beyond empirical therapeutic choices.
• Optimizing shock management requires evidence-based selection of catecholamines and alternative agents based on patient condition.